Hong Ren

机构：Central South University, Xiangya Hospital Central South University · ORCID：0009-0008-3933-6069

发表论文 18 篇 · 总被引 436 次 · h-index 8

代表论文

• Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer (2012 · Cancer Research · 被引 128)
• Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers (2021 · NEJM Evidence · 被引 78)
• Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas (2018 · Blood · 被引 65)
• Co‐delivery Nano System of MS‐275 and V‐9302 Induces Pyroptosis and Enhances Anti‐Tumor Immunity Against Uveal Melanoma (2024 · Advanced Science · 被引 45)
• cGAS‐STING Pathway Activation and Systemic Anti‐Tumor Immunity Induction via Photodynamic Nanoparticles with Potent Toxic Platinum DNA Intercalator Against Uveal Melanoma (2023 · Advanced Science · 被引 37)
• LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway (2022 · Acta Biochimica et Biophysica Sinica · 被引 28)